Compare CSX Corporation (CSX) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Sanofi SA — how do they compare? CSX Corporation trades at $50.03 (market cap $92.88B), while Sanofi SA trades at $43.25 (market cap $104.57B). The key difference: CSX Corporation and Sanofi SA are close in size by market cap, and Sanofi SA pays the higher dividend (5.56%). Which is the better fit depends on your goals.
| CSX | SNY | |
|---|---|---|
Market Cap | $92.88B | $104.57B |
Sector | Industrials | Health |
52-Week High | $53.21 | $52.34 |
52-Week Low | $32.05 | $41.33 |
Enterprise Value | $110.85B | $124.48B |
Dividend Yield | 1.12% | 5.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
